In This Article:
Wells Fargo analyst Joseph O’Dea raised the firm’s price target on Emerson (EMR) to $135 from $128 and keeps an Overweight rating on the shares. Portfolio news today marks a critical step toward finalizing a multi-year effort in transforming Emerson to pure-play automation, which the firm thinks can drive a re-rating. Wells adds that operational execution in Q4 remained solid and the outlook for 2025 is encouraging.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EMR: